Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunnar Hillerdal

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Archives of Environmental & Occupational Health|May 5, 2010
Endemic malignant mesothelioma: exposure to erionite is more important than genetic factorsMuzaffer Metintas, Gunnar Hillerdal, Selma Metintas, et al.
Lakartidningen|December 11, 2019
[Thoracal actinomycosis - a diagnostic challenge]Andreas Palm, Johan Isaksson, Eva Brandén, et al.
The Oncologist|March 4, 2015
Pemetrexed and gemcitabine versus carboplatin and gemcitabine in non-small cell lung cancer: a randomized noninferiority phase II study in one centerEva Branden, Gunnar Hillerdal, Karl Kolbeck, et al.
Lakartidningen|September 19, 2013
[Fast track assessment of lung cancer cut the investigation time in half]Karl-Gustaf Kölbeck, Susan Kamareji, Hans Jacobsson, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2002
The 'reservoir' of undetected bronchial carcinomas in the general populationHirsh Koyi, Gunnar Hillerdal, Eva Brandén, et al.
Respiratory Medicine|December 14, 2004
Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive valueValiant Ukale, Veronica Agrenius, Olle Widström, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drugValiant Ukale, Veronica Agrenius, Gunnar Hillerdal, et al.
Acta Oncologica (Stockholm, Sweden)|August 25, 2016
Lung cancer among native and foreign-born Swedes: histopathology, treatment, and survivalHirsh Koyi, Gunnar Hillerdal, Olov Andersson, et al.
Respiratory Medicine|July 4, 2021
Mesothelioma in immigrants from Turkey: Genes have a minor roleSelma Metintas, Muzaffer Metintas, Guntulu Ak, et al.
The Clinical Respiratory Journal|March 20, 2010
Treatment of malignant pleural mesothelioma with liposomized doxorubicine: prolonged time to progression and good survival. A Nordic studyGunnar Hillerdal, Jens Benn Sorensen, Stein Sundström, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Archives of Environmental & Occupational Health|May 5, 2010
Endemic malignant mesothelioma: exposure to erionite is more important than genetic factorsMuzaffer Metintas, Gunnar Hillerdal, Selma Metintas, et al.
Lakartidningen|December 11, 2019
[Thoracal actinomycosis - a diagnostic challenge]Andreas Palm, Johan Isaksson, Eva Brandén, et al.
The Oncologist|March 4, 2015
Pemetrexed and gemcitabine versus carboplatin and gemcitabine in non-small cell lung cancer: a randomized noninferiority phase II study in one centerEva Branden, Gunnar Hillerdal, Karl Kolbeck, et al.
Lakartidningen|September 19, 2013
[Fast track assessment of lung cancer cut the investigation time in half]Karl-Gustaf Kölbeck, Susan Kamareji, Hans Jacobsson, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2002
The 'reservoir' of undetected bronchial carcinomas in the general populationHirsh Koyi, Gunnar Hillerdal, Eva Brandén, et al.
Respiratory Medicine|December 14, 2004
Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive valueValiant Ukale, Veronica Agrenius, Olle Widström, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drugValiant Ukale, Veronica Agrenius, Gunnar Hillerdal, et al.
Acta Oncologica (Stockholm, Sweden)|August 25, 2016
Lung cancer among native and foreign-born Swedes: histopathology, treatment, and survivalHirsh Koyi, Gunnar Hillerdal, Olov Andersson, et al.
Respiratory Medicine|July 4, 2021
Mesothelioma in immigrants from Turkey: Genes have a minor roleSelma Metintas, Muzaffer Metintas, Guntulu Ak, et al.
The Clinical Respiratory Journal|March 20, 2010
Treatment of malignant pleural mesothelioma with liposomized doxorubicine: prolonged time to progression and good survival. A Nordic studyGunnar Hillerdal, Jens Benn Sorensen, Stein Sundström, et al.
Pageof 6